By: Chris Ryan
Two patients experienced 18% and 20% reductions in tumor size following treatment with camsirubicin.
Chris Ryan is a New York Jets reporter for NJ Advance Media. He has written for various publications including NJ.com, Staten Island Advance, New York Daily News, The Ringer, and more. Chris often covers topics such as oncology, clinical trials, lymphoma, myeloma, and pancreatic cancer.
This information evolves through machine learning and human feedback. Improve this profile .